The Testa Challenge 2022 participants are ...

AnalysisMode is an AI web-based virtual bioreactor (in-silico) empowering biotech scientists to run thousands of virtual cell culture experiments – in minutes. Their latest AI software product called CellSim, transforming a one-week cell-culture experiment into just a one-day simulation. For the year 2022, their mission is focused to reduce the cost of manufacturing CAR-T cell therapy in 3 simple steps: simulating the upstream process in a bioreactor, recommending culture media, and optimizing bioprocess steps. 

ArgusEye provides an innovative sensor system for next-generation bioprocessing enabling in-line, real-time detection of critical quality attributes and process parameters during the development and production of biopharmaceuticals. Their patented sensor technology is the result of extensive academic research and is based on nanoplasmonic sensing combined with fiber optics. By adding customized receptors ArgusEye can offer flexible and sensitive sensor systems for a variety of targets.

Nyctea delivers a new solution for the processing of biopharmaceuticals that improves productivity. We invented a surface that purifies biomolecules by electronic signals that replace the use of problematic chemicals in the production process, giving faster production and higher yield. Our product makes it possible to manufacture more kinds of biopharmaceuticals, accelerating the development of new treatments.

Scitara is a global provider of laboratory-specific, cloud-based software solutions for the life sciences and other science-based industries. Scitara’s solutions are powering the digital transformation of scientific laboratories by enabling them with modern lab data connectivity infrastructure and tools to accelerate science.​

Timegate is a deep tech company founded in 2014 to provide digitalization tools to process industries. Timegate’s innovation provides a solution to measure multiple critical process parameters like nutrients and metabolites in real-time and without manual sampling to know what’s going on in the bioreactors.

We are happy to announce these five companies, selected by an external advisory board. The competition to join this year's Testa Challenge 2022 was keen with many strong applicants from around the world. 

The countdown to the Testa Challenge weeks in march has now begun and we look forward to welcoming the selected companies to Testa Center.

// The Testa Challenge team